Analysts review TG Therapeutics Inc’s rating
TG Therapeutics Inc’s filing revealed that its Director Echelard Yann acquired Company’s shares for reported $0.49 million on Nov 05
TG Therapeutics Inc’s filing revealed that its Director Echelard Yann acquired Company’s shares for reported $0.49 million on Nov 05
TG Therapeutics Inc’s filing revealed that its Director Lonial Sagar unloaded Company’s shares for reported $0.28 million on Jun 20
TG Therapeutics Inc’s recently made public that its Director Lonial Sagar unloaded Company’s shares for reported $0.28 million on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. TG Therapeutics
TG Therapeutics Inc’s recently made public that its Director Lonial Sagar unloaded Company’s shares for reported $0.28 million on Jun
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. TG Therapeutics
In a filing, TG Therapeutics Inc revealed its Director Lonial Sagar unloaded Company’s shares for reported $0.28 million on Jun
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.